Table 3

Association of Stasys assays and patients receiving transfusions

Transfusions at 0–6 hoursTransfusions at 0–24 hours
Any products
(n=32; 30%)
pRBCs
(n=31; 29%)
FFP
(n=27; 25%)
PLT
(n=14; 11%)
Any products
(n=34; 31%)
pRBCs
(n=33; 30%)
FFP
(n=29; 27%)
PLT
(n=17; 14%)
Platelet contractile force
 Cumulative25 593
(0.04*)
25 193
(0.04*)
25 832
(0.12)
24 815
(0.18)
29 570
(0.02*)
33 308
(0.03*)
33 301
(0.09)
33 569
(0.37)
 Maximum203.27
(0.04*)
206.40
(0.06)
200.13
(0.06)
174.32
(0.03*)
207.26
(0.02*)
208.11
(0.03*)
205.88
(0.03*)
198.50
(0.09)
Clot area
 Cumulative55.40
(0.99)
52.52
(0.95)
49.74
(0.51)
49.40
(0.99)
56.42
(0.57)
51.59
(0.54)
49.74
(0.22)
49.46
(0.71)
 Maximum0.26
(0.72)
0.26
(0.83)
0.24
(0.69)
0.23
(0.89)
0.26
(0.80)
0.26
(0.92)
0.26
(0.62)
0.22
(0.81)
  • Data presented as median and p values for comparison of transfused versus non-transfused patients, using Kruskal-Wallis test listed above. Portion of cohort receiving transfusion reported as absolute value and percentage.

  • *Indicates statistically significant findings of p≤0.05.

  • FFP, fresh frozen plasma; PLT, platelets; pRBCs, packed red blood cells.